[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE03137B1 - Veterinaarravim ja protsess selle valmistamiseks - Google Patents

Veterinaarravim ja protsess selle valmistamiseks

Info

Publication number
EE03137B1
EE03137B1 EE9400377A EE9400377A EE03137B1 EE 03137 B1 EE03137 B1 EE 03137B1 EE 9400377 A EE9400377 A EE 9400377A EE 9400377 A EE9400377 A EE 9400377A EE 03137 B1 EE03137 B1 EE 03137B1
Authority
EE
Estonia
Prior art keywords
preparation
medicinal product
veterinary medicinal
composition
veterinary
Prior art date
Application number
EE9400377A
Other languages
English (en)
Inventor
Arthur Olovson Stig-G�ran
Gunnar Pilbrant Ke
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE03137B1 publication Critical patent/EE03137B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9400377A 1993-04-30 1994-11-17 Veterinaarravim ja protsess selle valmistamiseks EE03137B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301489A SE9301489D0 (sv) 1993-04-30 1993-04-30 Veterinary composition

Publications (1)

Publication Number Publication Date
EE03137B1 true EE03137B1 (et) 1998-12-15

Family

ID=20389791

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400377A EE03137B1 (et) 1993-04-30 1994-11-17 Veterinaarravim ja protsess selle valmistamiseks

Country Status (33)

Country Link
US (1) US5731002A (et)
EP (1) EP0696921B1 (et)
JP (1) JP3872509B2 (et)
KR (1) KR100324451B1 (et)
CN (1) CN1100570C (et)
AT (1) ATE199060T1 (et)
AU (1) AU678830B2 (et)
BR (1) BR9406363A (et)
CZ (1) CZ285191B6 (et)
DE (1) DE69426669T2 (et)
DK (1) DK0696921T3 (et)
EE (1) EE03137B1 (et)
EG (1) EG20401A (et)
ES (1) ES2155473T3 (et)
FI (1) FI955124A0 (et)
GR (1) GR3035831T3 (et)
HR (1) HRP940267A2 (et)
HU (1) HUT74868A (et)
IL (1) IL109245A (et)
IS (1) IS1694B (et)
LT (1) LT3263B (et)
MA (1) MA23170A1 (et)
NO (1) NO312435B1 (et)
NZ (1) NZ265728A (et)
PL (1) PL176755B1 (et)
PT (1) PT696921E (et)
RU (1) RU2131267C1 (et)
SE (1) SE9301489D0 (et)
SG (1) SG52540A1 (et)
SK (1) SK280465B6 (et)
TN (1) TNSN94035A1 (et)
WO (1) WO1994025070A1 (et)
YU (1) YU22794A (et)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
AU773696B2 (en) * 1998-10-06 2004-06-03 Mars, Incorporated Animal stereotypy
DK1156806T3 (da) * 1999-02-23 2004-08-02 Merck & Co Inc Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
EP1341523B1 (en) 2000-12-07 2013-01-23 Nycomed GmbH Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
CA2430816C (en) * 2000-12-07 2012-05-15 Altana Pharma Ag Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
JP5148813B2 (ja) * 2002-07-03 2013-02-20 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド プロトンポンプ阻害剤の液体剤形
US20040005362A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
ATE454906T1 (de) * 2003-07-11 2010-01-15 Astrazeneca Ab Feste zusammensetzung mit einem protonenpumpenhemmer
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20050249806A1 (en) * 2004-02-10 2005-11-10 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
EP1698233A1 (en) * 2005-03-01 2006-09-06 Bayer HealthCare AG Reduction of digestibility of phosphorus in animal nutrition
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US9233092B2 (en) 2006-07-25 2016-01-12 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2009062939A1 (en) * 2007-11-15 2009-05-22 Novartis Ag Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
US20090227633A1 (en) * 2008-03-04 2009-09-10 Bassam Damaj Methods to inhibit tumor cell growth by using proton pump inhibitors
JP2014530855A (ja) * 2011-10-19 2014-11-20 アール．ピー． シェーラーテクノロジーズ エルエルシー 二相式薬剤送達システム
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US20190151297A1 (en) * 2016-04-29 2019-05-23 Nauts Equine Brand Pty Ltd Veterinary Composition
CN107468652A (zh) * 2016-06-07 2017-12-15 北京新领先医药科技发展有限公司 一种固体干混悬温敏凝胶剂及其制备方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3496714A4 (en) 2016-08-11 2020-04-22 Adamis Pharmaceuticals Corporation DRUG COMPOSITIONS.
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL22368A (en) * 1963-11-19 1969-01-29 Merck & Co Inc 2,5(or 6)-bis-heteroaryl substituted benzazoles
BE792990A (fr) * 1971-12-23 1973-06-19 Shell Int Research Procede de lutte contre les endoparasites chez les chevaux
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5215974A (en) * 1986-11-21 1993-06-01 Aktiebolaget Hassle Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
WO2011034149A1 (ja) 2009-09-18 2011-03-24 旭硝子株式会社 二次電池用非水電解液

Also Published As

Publication number Publication date
HUT74868A (en) 1997-02-28
SK280465B6 (sk) 2000-02-14
EP0696921A1 (en) 1996-02-21
AU6693894A (en) 1994-11-21
JPH08509493A (ja) 1996-10-08
EG20401A (en) 1999-02-28
TNSN94035A1 (fr) 1995-04-25
JP3872509B2 (ja) 2007-01-24
LTIP1920A (en) 1994-11-25
FI955124A (fi) 1995-10-27
HRP940267A2 (en) 1996-10-31
DK0696921T3 (da) 2001-03-19
IS4146A (is) 1994-10-31
WO1994025070A1 (en) 1994-11-10
DE69426669D1 (de) 2001-03-15
PL311276A1 (en) 1996-02-05
LT3263B (en) 1995-05-25
ES2155473T3 (es) 2001-05-16
EP0696921B1 (en) 2001-02-07
NO954240L (no) 1995-10-23
PT696921E (pt) 2001-06-29
BR9406363A (pt) 1996-02-27
CZ285191B6 (cs) 1999-06-16
SG52540A1 (en) 1998-09-28
YU22794A (sh) 1998-05-15
AU678830B2 (en) 1997-06-12
PL176755B1 (pl) 1999-07-30
US5731002A (en) 1998-03-24
GR3035831T3 (en) 2001-08-31
IS1694B (is) 1998-04-20
SE9301489D0 (sv) 1993-04-30
IL109245A0 (en) 1994-11-28
NO954240D0 (no) 1995-10-23
MA23170A1 (fr) 1994-12-31
KR100324451B1 (ko) 2002-11-01
CZ282595A3 (en) 1996-04-17
NZ265728A (en) 1996-12-20
CN1122109A (zh) 1996-05-08
RU2131267C1 (ru) 1999-06-10
CN1100570C (zh) 2003-02-05
DE69426669T2 (de) 2001-07-05
IL109245A (en) 2000-07-16
NO312435B1 (no) 2002-05-13
HU9503085D0 (en) 1995-12-28
ATE199060T1 (de) 2001-02-15
FI955124A0 (fi) 1995-10-27
SK135495A3 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
EE03137B1 (et) Veterinaarravim ja protsess selle valmistamiseks
BR9604803A (pt) Composição farmacêutica para administração oral
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
BR9506029A (pt) Forma farmaêutica oral de múltipla dosagem unitária em tablete processo para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem para o tratamento de doenças inflamatórias gastrointestinais em maniferos e no homem e embalgem de ampola de pressão transversal
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
MX9806188A (es) Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
TH17624A (th) สูตรผสมทางสัตวแพทย์
UA885A1 (uk) Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.
ES2158871T3 (es) Uso de una formulacion de calcio en un medicamento para la aplicacion terapeutica a vacas lecheras que sufren hipocalcemia.
UA19287A (uk) Діетиламіhоетиламіда 1-пропіл-2-оксо-4-гідроксіхіhолін-3-карбонової кислоти гідрохлорид, що проявляє анестезуючу, протиаритмічhу, аhтиоксидаhтhу, аhтимікробну та фуhгіцидhу активhість